The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Linking the companion diagnostic function of cancer genome profiling to therapy: Investigation of TMB-high predictors.
 
Emiko Hiraoka
No Relationships to Disclose
 
Akiko Emi
No Relationships to Disclose
 
Hikaru Nakahara
No Relationships to Disclose
 
Asuka Toshida
No Relationships to Disclose
 
Kanako Suzuki
No Relationships to Disclose
 
Mutsumi Fujimoto
No Relationships to Disclose
 
Haruka Ikejiri
No Relationships to Disclose
 
Ai Amioka
No Relationships to Disclose
 
Shinsuke Sasada
No Relationships to Disclose
 
Mihoko Doi
No Relationships to Disclose
 
Taizo Hirata
No Relationships to Disclose
 
Tomoyuki Yoshiyama
No Relationships to Disclose
 
Ichiko Yamakita
No Relationships to Disclose
 
Yuki Kaneko
No Relationships to Disclose
 
Tomoko Itagaki
No Relationships to Disclose
 
Keiko Kajitani
No Relationships to Disclose
 
Hideo Shigematsu
No Relationships to Disclose
 
Takao Hinoi
Speakers' Bureau - Lilly Japan; Merck KGaA; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Chugai Pharma
 
Morihito Okada
Speakers' Bureau - AstraZeneca; Chugai Pharma; Covidien; CSL Behring; Johnson & Johnson; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Johnson & Johnson (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); Nihon Medi-Physics (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)